openPR Logo
Press release

Converging Factors Driving the Growth of Dry Powder Inhaled Delivery

04-25-2017 09:53 AM CET | Health & Medicine

Press release from: Greystone Research Associates

(Amherst, NH) – The search for improved routes of administration for therapeutic agents and the desire for noninvasive delivery methods for self-medication of chronic conditions have led to increased interest in pulmonary drug delivery systems. Recent developments, including ongoing research activity in powder formulations, advances in particle engineering, and novel device architectures are positioning dry powder inhalation as an attractive option for pharma and biotech product strategists in this age of direct-to-consumer marketing.

Inhalers for the treatment of upper respiratory ailments (URT) such as asthma and chronic obstructive pulmonary disease are arguably the most mission-critical drug delivery device class currently on the market. These combination products are relied upon by tens of millions of Americans and more than 300 million worldwide for the treatment of debilitating and life-threatening respiratory conditions. While accounting for nine out of every ten dollars spent on inhaled therapeutics, much of the recent activity for URT has focused on the rise of generics as patents expire and on COPD, a growing segment that continues represent significant unmet needs

Orally inhaled drug delivery is being transformed by recent developments in particle technology. Powder formulations predominantly used in commercial inhalers consist of coarse carrier particles blended with micronized drug particles. This approach can lead to significant variability in dose-to-dose drug administration. While improvements and enhancements in inhaler designs attempt to address these issues, enabling technologies in the area of particle engineering are creating new opportunities for dry powder inhalation.

As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies, inhaled medicine is increasingly being viewed as patient-friendly and cost-effective. Our analysis demonstrates that inhaled administration in general, and DPI in particular, are well positioned to take advantage of these trends and evolve into a significant factor in the future of pharmaceutical development and commercialization of therapeutic drugs.

While the market for inhaled drugs targeting upper respiratory diseases such as asthma and COPD is maturing technologically with most development activity now centering on expanded indications and combination drug inhalers, several participants in this sector are taking novel approaches that attempt to address underlying causes as opposed to treating disease symptoms. Many challenges remain, but as a group these candidates hold significant potential.

Detailed analysis of Dry Powder Inhalers and Inhalation products, therapeutic sectors, and participants is included in a new and comprehensive report. The report documents and analyzes the results of a recent survey of inhaled drugs markets conducted by Greystone Research Associates.

More information is available at
https://greystoneassociates.org/drug-delivery/inhaled-drug-delivery/dry-powder-inhalers-market-report/



Source: Greystone Research Associates

About Greystone

Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Converging Factors Driving the Growth of Dry Powder Inhaled Delivery here

News-ID: 512995 • Views:

More Releases from Greystone Research Associates

Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors. A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population. To fully address the unmet need these technologies
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from

All 5 Releases


More Releases for Amherst

Future Growth : Crop Nutrient Management Market Sees Promising Growth in 2022 SM …
Worldwide Market Reports has added a new research study on Global "Crop Nutrient Management Market" 2022 by Size, Growth, Trends, and dynamics, Forecast to 2028 which is a result of an extensive examination of the market patterns. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of
A New Generation of Glucose Sensors is Creating Options for Caregivers and their …
(Amherst, NH) – The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. New glucose sensors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By utilizing new technologies for sensing glucose, this new class of sensors is creating new options for caregivers and their diabetes patients. Signal
New Aircraft Designs Creating Opportunities for High Performance Aerospace Coati …
(Amherst, NH) – As aerospace manufacturers and their engineering teams push the design envelope to create aircraft with better fuel efficiency and lower maintenance requirements, they are relying increasingly on engineered materials for a growing list of structural and non-structural elements and components. This trend is changing the way aircraft are developed, produced and maintained. It’s also presenting opportunities for specialty materials suppliers with products that can improve production
Evolution in Markets for Radiation Curable Coatings Creating Risks and Opportuni …
(Amherst, NH) – Recent advances in materials and equipment are creating new demand for radiation curable coatings in a number of industrial applications. This new demand is occurring as several technology advances are being brought into the marketplace. By removing some of the key limitations of radcure coatings, these advances are enabling radcure coatings to meet unique application requirements, opening up a number of new opportunities. Technical advances that are having
Adhesive Films and Tapes Evolving to Address Demands of Emerging Applications
(Nashua, NH) – Recent advances in adhe¬sives technology are creating new opportunities for adhesive films and tapes in a number of industrial applications. These adhesive products are finding new structural bonding and join¬ing applications in the automo¬tive, aerospace, and electronics markets. Films and tapes with enhanced performance are reaching the market as several important developments are occurring which will spur new demand. These findings are contained in a new market
Adros Energy Expands Clean Energy Business with Energy Audit Services and opens …
Adros Energy; a leading green energy company in New England, announced today that they are opening a new headquarters in Amherst, NH after a successful 1st year of operation in the renewable energy market. The company was founded in January of 2009 and has found success during the incubation period of the company. The infrastructure building of the company in 2009 includes: • Revenue generation from its solar PV,